Medicared For All Logo

Tatyana Feldman MD in Hackensack, New Jersey

Home New Jersey Hackensack

Tatyana Feldman MD has Hematology/oncology as her primary medical specialty. Their primary office is: 92 2nd St in Hackensack, New Jersey.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 201-996-5900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1992 (around 33 years of experience). They are listed as doing telehealth appointments.


Tatyana Feldman MD Office Phone and Directions

Tatyana Feldman MD
Regional Cancer Care Associates Llc
92 2nd St
Hackensack, New Jersey 07601
201-996-5900


Patient Ratings
Please rate your experience with Tatyana Feldman MD below to help others make a more informed decision. Thanks!
Current Rating: No ratings yet

Phone: 201-996-5900


Enter a starting address:


Healthcare Info for Tatyana Feldman MD

Medical School: Sorry, her university is not listed
Graduation Year: 1992
The Primary Medical Specialty for Tatyana Feldman MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 1557366333
NPI #: 1578528089
NPI Created On: 04/18/2006
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207RH0000X
License Number:
25MA07424900
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • AmeriHealth New Jersey
  • Blue Cross Blue Shield
  • Humana
  • Oscar Garden State Insurance Corporation
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Russian, English, Spanish.


Services and Procedures include:

  1. Diagnostic bone marrow aspiration
  2. Bone marrow biopsy
  3. Bone marrow biopsy and aspiration
  4. Complete blood cell count (red cells, white blood cell, platelets), automated test
  5. Bone marrow, smear interpretation
  6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  7. Application of on-body injector for injection under skin
  8. New patient office or other outpatient visit, typically 60 minutes
  9. Established patient office or other outpatient visit, typically 15 minutes
  10. Established patient office or other outpatient, visit typically 25 minutes
  11. Established patient office or other outpatient, visit typically 40 minutes
  12. Initial hospital inpatient care, typically 70 minutes per day
  13. Subsequent hospital inpatient care, typically 35 minutes per day
  14. Hospital discharge day management, 30 minutes or less
  15. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
  16. Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
  17. Injection, pegfilgrastim, 6 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016919

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781016921

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $150

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832147705

Being Disputed:: No

Product Related: No


Payments Total: $1,235

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 832147819

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832147821

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Payments Total: $1,250

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 832339499

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: TAZVERIK

Open Associated Drug #1: 72607-100-00


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848573821

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: KEYTRUDA

Open Associated Drug #1: 0006-3029-02


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829370813

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CALQUENCE

Open Associated Drug #1: 0310-0512-28


Payments Total: $2,055

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 829414329

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CALQUENCE

Open Associated Drug #1: 0310-0512-28


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829706721

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CALQUENCE

Open Associated Drug #1: 0310-0512-28


Hematology/oncology Professionals in Hackensack

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group